PLUS THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-36.8% -$2M
$-6M
Free Cash Flow↓-172.7% -$19K
$-30K
Investing Cash Flow
$1M
Financing Cash Flow
$3M
Capex↑+172.7% +$19K
$30K
Stock Buybacks
$0
Stock-Based Comp↑+457.0% +$585K
$713K
Debt Issued
—
Debt Repaid
$0
D&A↓-58.3% -$203K
$145K
SBC Allocated Expense↑+457.0% +$585K
$713K
SBC Unrecognized Cost↑+4400.0% +$4M
$5M